Thermo Fisher Scientific completes sale of microbiology business to Astorg for $1.075 billion

M&A · Partnership
โดย Business Wire·US·Read original
Summary · why it matters

Thermo Fisher Scientific has completed the sale of its microbiology business to pan-European private equity firm Astorg for approximately $1.075 billion, consisting of cash and a $50 million seller note. The business, which provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing, generated $645 million in revenue in 2025 and was part of Thermo Fisher's Specialty Diagnostics segment.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks

Off-coverage companies 1

AstorgPrivate▲ Positive
Capitalrelevance

Acquired Thermo Fisher's microbiology business for $1.075 billion, expanding its portfolio.

© 2026 MarketDXNews